Literature DB >> 11746544

Consanguineous hemolytic uremic syndrome secondary to Escherichia coli O157:H7 infection treated with aggressive therapeutic plasma exchange.

K A Downes1, K Allen, R Sarode, R Yomtovian.   

Abstract

We describe the successful management of an elderly husband and wife with Escherichia coli O157:H7 associated hemolytic uremic syndrome (HUS) treated with aggressive therapeutic plasma exchange (TPE) with replacement with fresh frozen plasma. Following twelve TPEs (three 1.5 volume; nine 1 volume), the husband's platelet count increased from 45 x 10(9)/L to 183 x 10(9)/L. Following ten 1.5 volume TPEs, the wife's platelet count increased from 30 x 10(9)/L to 193 x 10(9)/L. This is the first known occurrence of E. coli O157:H7 associated HUS in an elderly husband and wife successfully treated with aggressive TPE. We conclude that early, aggressive TPE should be considered and may be life-saving for E coli O157:H7 associated HUS in the elderly. Copyright 2001 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2001        PMID: 11746544     DOI: 10.1002/jca.1029

Source DB:  PubMed          Journal:  J Clin Apher        ISSN: 0733-2459            Impact factor:   2.821


  1 in total

1.  The association between therapeutic plasma exchange and the risk of mortality among patients critically ill with COVID-19: a meta-analysis.

Authors:  Shinta Oktya Wardhani; Jonny Karunia Fajar; Gatot Soegiarto; Laksmi Wulandari; Helnida Anggun Maliga; Muhammad Ilmawan; Risna Merysa; Arlentina Bentivolia Simamora; Qurrata Aini; Komang Noviantari; Ayu Widya Lestari; Maria Yoheni Harnila; Imam Syafi'i; Jane Andrea Christiano Djianzonie; Nenci Siagian; Sri Nining; Risyda Zakiyah Hanim; Wahyuni Wahyuni; Fitri Aulia; Juliansyah Juliansyah; Reflin Mahmud; Fredo Tamara; Aditya Indra Mahendra; Amanda Cininta Wowor; Fikri Baladraf; Ponda Hernest Hadinata; Adhityari Ikkeputri; Hana Nadya; Dessy Aprilia Kartini; Milda Husnah; Firzan Nainu; Harapan Harapan
Journal:  F1000Res       Date:  2021-12-14
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.